Head of Evidence Generation

Ipsen is a dynamic and growing global specialty-driven biopharmaceutical company focused on innovation and specialty care.

We aim to make a sustainable difference by significantly improving patients’ health and quality of life and providing them with effective therapeutic solutions for unmet medical needs through differentiated and innovative medicines in Oncology, Neurosciences and Rare Diseases.

The patient is at the heart of everything we do, and we also care for our employees because they are the ambassadors who truly make the difference. We attract and develop bold, agile, entrepreneurial individuals who take full ownership of their decisions; leaders drawn by a purpose to make a direct impact through their work in people’s lives.

We offer employees a wealth of fulfilling challenges & growth opportunities, and the chance to contribute within a fast-moving organisation, an organisation that is genuinely game-changing.

The **Head of Evidence Generation - International Region Senior Director**will **lead the development and direction of the Ipsen International (EX US & Canada) evidence generation strategy (Phase IV, ISS, RWE)** to support Ipsen’s medical objectives across all therapeutic areas (Oncology, Rare diseases and Neurotoxins).

**This role is pivotal in shaping and delivering high-quality clinical and real-world evidence (RWE)**that informs decision-making, supports access, and enhances patient outcomes.

**It requires strong leadership, scientific rigor, and cross-functional collaboration to ensure alignment with global strategies and local market needs**.

**Main Responsibilities**:
**Strategic Leadership**
- Responsible for developing strategies for evidence generation (Phase IV, ISS, RWE) at International that support healthcare clinical evidence gaps and the LCM of our products
- Assess the local needs and build proposal for scaling RWE capabilities (HC, resources, operating model) at International countries
- Define and implement the International Evidence Generation Plan (IEGP) in alignment with global medical strategies and local evidence needs.
- Provide budget input for activities related to Epidemiology and RWE studies and initiatives ensuring projects are adequately resourced

**Evidence Generation Execution**
- Ensure that the Global IEGP is well implemented at local level and the country data gaps are well integrated in the IEGP (Global & Local) in alignment with lifecycle management (LCM) priorities
- Oversee the planning, execution, and reporting of evidence generation projects (clinical studies, RWE, health outcomes research) across the region.
- Ensure scientific, ethical, and regulatory standards are met in all research activities
- Support country teams in project design and EGRB submission readiness

**Cross-Functional Collaboration**
- Partner with Country medical directors, asset medical leads, market access, clinical operations, and HEOR to align evidence generation with business objectives

**Capability Building**
- Lead the development of RWE capabilities at the Local/regional level, including operating models, resources, and trainings
- Foster a culture of innovation and scientific excellence in evidence generation

**External Engagement**
- Identify key research opportunities, including clinical studies, real-world evidence projects, and health outcomes research and foster partnerships and collaborations with institutions at International

In order to be considered for this role you must have:

- Advanced degree in life sciences, medicine, epidemiology, or related field (MD, PharmD, PhD preferred)
- **Extensive experience** in medical affairs, RWE**:

- **Proven track record in leading regional or global evidence generation strategies**:

- ** Experience with RWE, observational studies, and regulatory-grade data generation**:

- Experience** leading external analytic and evidence generating activities**

You will have **exceptional leadership and influencing skills.**

**Fluency in English.**

LI-HYBRID